[Skip to Content]
[Skip to Content Landing]
Comment & Response
January 27, 2015

Ethical Testing of Experimental Ebola Treatments

Author Affiliations
  • 1School of Population and Public Health, University of British Columbia, Vancouver, Canada
  • 2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • 3Stanford Prevention Research Center, Stanford University, Stanford, California
JAMA. 2015;313(4):421-422. doi:10.1001/jama.2014.17259

To the Editor Dr Joffe1 argued for the importance of randomized study designs to ensure the acquisition of scientific knowledge required for the response to the Ebola epidemic to progress, as well as to ensure ethical treatment of patients. Many calls for RCTs have culminated with the establishment, by the Wellcome Trust, of an international consortium to conduct clinical trials of experimental therapeutics for Ebola virus disease in West Africa.2